0001127602-21-019456.txt : 20210608 0001127602-21-019456.hdr.sgml : 20210608 20210608184422 ACCESSION NUMBER: 0001127602-21-019456 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210607 FILED AS OF DATE: 20210608 DATE AS OF CHANGE: 20210608 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ANSTICE DAVID W CENTRAL INDEX KEY: 0001181171 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35299 FILM NUMBER: 211003413 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Alkermes plc. CENTRAL INDEX KEY: 0001520262 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981007018 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CONNAUGHT HOUSE STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN 4 STATE: L2 ZIP: 00000 BUSINESS PHONE: 00-353-1-772-8000 MAIL ADDRESS: STREET 1: CONNAUGHT HOUSE STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN 4 STATE: L2 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: ANTLER SCIENCE TWO PLC DATE OF NAME CHANGE: 20110804 FORMER COMPANY: FORMER CONFORMED NAME: Antler Science Two Ltd DATE OF NAME CHANGE: 20110509 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2021-06-07 0001520262 Alkermes plc. ALKS 0001181171 ANSTICE DAVID W CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 IRELAND 1 Ordinary Shares 2021-06-07 4 M 0 5000 14.60 A 78081 D Ordinary Shares 2021-06-07 4 S 0 5000 24.00 D 73081 D Non Qualified Stock Option (Right to Buy) 14.60 2021-06-07 4 M 0 5000 0 D 2021-10-05 Ordinary Shares 5000 20000 D This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. These options are fully vested in accordance with their terms. /s/ Shantale Greenson, attorney-in-fact for David W. Anstice 2021-06-08